<DOC>
	<DOCNO>NCT00973427</DOCNO>
	<brief_summary>The purpose study determine whether DNA chip , design Medical Prognosis Institute ( MPI ) , provide accurate prognosis survival NSCLC ( adeno- , squamous large cell lung cancer ) .</brief_summary>
	<brief_title>DNA Chip Based Prognosis Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>1 . A histological diagnosis primary NSCLC stage Ia 2 . Surgical removal tumor 3 . Age 18 75 year 4 . Ability understand willingness sign write informed consent document . 1 . A primary NSCLC stage Ia diagnosis change primary NSCLC NSCLC stage IbIV surgery . 2 . Adjuvant treatment chemotherapy . 3 . Prior history cancer past 5 year breast cancer time . 4 . Life expectancy le 3 year opinion investigator due concurrent illness .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>NSCLC</keyword>
</DOC>